Our Latest Customer Stories

Impetus has proven success in improving outcomes for their clients’ and partners’ advisory boards, working groups, investigator meetings, online medical education/learning programs, and more. See for yourself in the customer stories below!

Scientific Workshop & Consensus Paper Development: A Customer Story

folder_openCustomer Stories
Our client, a leader in the endocrinology sector, faced the challenge of launching a product in new indications without established treatment guidelines. To navigate this complex scenario, they turned to Impetus Digital’s innovative virtual platform and strategic experts. Through a combination of asynchronous data reviews, insight-gathering, patient…

Online Investigator Meetings: A Customer Story

folder_openClinical Trials, Customer Stories, Patient Engagement
Our client leveraged Impetus Digital’s virtual solutions to hold a series of investigator meetings and streamline their multicenter Phase III clinical trial. Using a mix of synchronous and asynchronous virtual touchpoints, as well as an online Investigator Community Board, Impetus facilitated ongoing collaboration, best practice-sharing, and problem-solving,…

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

folder_openCustomer Stories, Patient Engagement
In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning LEEP™ to conduct an informal needs assessment, map out all required external stakeholder engagements, and identify suitable investigators. The ultimate goal of all (completed and planned)…
Travel-related emissions are contributing to global warming; virtual meetings are one tool to fight the climate crisis.

Case Study: Reducing the Environmental Impact of Pharmaceutical Advisory Boards

folder_openCustomer Stories, Improve Your Advisory Boards
The Problem With in-person meetings resuming after the end of COVID-19-related restrictions, many of our clients have been eager to get back to these meetings, thinking that’s what their Key Opinion Leaders (KOLs) want. Traditionally, external pharmaceutical meetings such as national advisory boards are held at upscale…